Publications in VIVO

Co-author Network

Mariam Nawas, MD

Person

Positions

Assistant Professor, University of Chicago

Clinical Disciplines

Publications
Other
View All

Selected Publications

article
1. Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post-revumenib therapies.. British journal of haematology. 2025
2. Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations.. Blood advances. 9:3395-3407. 2025
3. Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Therapy.. Transplantation and cellular therapy. 31:756-773. 2025
4. Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT.. Transplantation and cellular therapy. 31:774-788. 2025
5. Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax Therapy.. EJHaem. 6:-. 2025
6. US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for Transplantation and Cellular Therapy Physician Survey from the Aging Special Interest Group and Committee on Practice Guidelines.. Transplantation and cellular therapy. 31:285-296. 2025
7. Molecular measurable residual disease monitoring and transplant indications in NPM1 mutated acute myeloid leukemia.. Bone marrow transplantation. 60:135-143. 2024
8. Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation.. Haematologica. 109:3739-3744. 2024
9. Optimization of Older Adults by a Geriatric Assessment-Guided Multidisciplinary Clinic Prior to CAR T-Cell Therapy.. Blood advances. 8:3785-3797. 2024
10. Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms.. Blood cancer journal. 14:-. 2024
11. FLT3. Annals of translational medicine. 12:-. 2024
12. Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy.. Leukemia & lymphoma. 65:1-4. 2024
13. Utility or Futility? A Contemporary Approach to Allogeneic Hematopoietic Cell Transplant in TP53-Mutated MDS and AML.. Blood advances. 8:553-561. 2024
14. Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults.. Blood advances. 8:164-171. 2024
15. Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.. Clinical lymphoma, myeloma & leukemia. 24:83-93. 2023
16. Higher graft cell dose does not influence development of acute or chronic GVHD in haploidentical transplantation using PTCy.. Blood advances. 7:4475-4478. 2023
17. FLT3. Haematologica. 108:2234-2239. 2023
18. Linking Body Composition and Nutritional Status with CAR T-cell Efficacy.. Cancer immunology research. 11:-. 2023
19. Dynamic EASIX Scores Closely Predict Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation.. Blood advances. 6:5898-5907. 2022
20. The Cup Runneth Over: Treatment Strategies for Newly Diagnosed Acute Myeloid Leukemia.. JCO oncology practice. 19:-. 2022
21. CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis.. Bone marrow transplantation. 57:1101-1107. 2022
22. Optimizing Hematopoietic Cellular Transplantation in Older Adults with Hematologic Malignancies. Advances in oncology. 2022
23. Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves.. Transplantation and cellular therapy. 2021
24. Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020
25. Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation.. Journal of geriatric oncology. 2020
26. The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation.. Blood reviews. 2020
27. Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019
28. A Protean Protein.. Journal of hospital medicine. 2018
29. Complicated necrotizing otitis externa.. American journal of otolaryngology. 2013
document
1. Real World Predictors of Response and 24-month survival in high-grade TP53-mutated Myeloid Neoplasms 2024